Cargando…

A retrospective analysis of the treatment on abdominal aortic balloon occlusion-related thrombosis by continuous low-flow diluted heparin

Thrombosis is one of the serious complications related to prophylactic balloon occlusion of the abdominal aorta (PBOAA). This study aims to retrospectively analyze the efficacy and safety of continuous low-flow infusion of diluted heparin saline to prevent this complication related to PBOAA and furt...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Rongguang, Wang, Fen, Guan, Yanxing, Wan, Junhui, Zhang, Wentao, Duan, Zhifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940061/
https://www.ncbi.nlm.nih.gov/pubmed/31861017
http://dx.doi.org/10.1097/MD.0000000000018446
_version_ 1783484285880107008
author Luo, Rongguang
Wang, Fen
Guan, Yanxing
Wan, Junhui
Zhang, Wentao
Duan, Zhifeng
author_facet Luo, Rongguang
Wang, Fen
Guan, Yanxing
Wan, Junhui
Zhang, Wentao
Duan, Zhifeng
author_sort Luo, Rongguang
collection PubMed
description Thrombosis is one of the serious complications related to prophylactic balloon occlusion of the abdominal aorta (PBOAA). This study aims to retrospectively analyze the efficacy and safety of continuous low-flow infusion of diluted heparin saline to prevent this complication related to PBOAA and further to provide the theory and evidences for using PBOAA. A study was carried out at our hospital from March 2016 to December 2018. Women with pernicious placenta previa (PPP) were treated PBOAA to prevent massive bleeding during CS. According to whether continuous low-flow infusion of diluted heparin saline was used to prevent catheter-related thrombosis or not, they were divided into 2 groups, the test group and the control group. The incidence of thrombosis between the 2 groups was compared and the effective treatment of thrombosis was also discussed. The comparison of nonparametric values was accomplished by using Fisher exact test. Statistical significance was set at P < .05. There were 31 women with PPP who received PBOAA during CS who were included in our study. Six of 19 women in control group (31.6%) developed thrombotic complications, while none of 12 women in test group. There were statistically significant differences in the incidence of thrombosis between the 2 groups (P = .037). There was no statistically significant difference in the amount of estimated blood loss and blood transfusion during CS between the 2 groups, nor was there statistically significant difference in the hospital days after CS (P > .05). All 6 women with thrombotic complications had no positive symptoms and thrombotic sequelae. The managements of thrombus included systemic anticoagulation, catheter-directed thrombolysis, and catheter-directed anticoagulation. One of the 6 women was lost to follow-up, and the thrombus of the other 5 women were completely dissolved. No other adverse outcomes or complications related to PBOAA were observed in all women in this study. Continuous low-flow infusion of diluted heparin saline is a safe procedure when PBOAA is performed for patients with PPP. It can effectively reduce or even avoid thrombosis without increasing intraoperative blood loss during CS for PPP patients.
format Online
Article
Text
id pubmed-6940061
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-69400612020-01-31 A retrospective analysis of the treatment on abdominal aortic balloon occlusion-related thrombosis by continuous low-flow diluted heparin Luo, Rongguang Wang, Fen Guan, Yanxing Wan, Junhui Zhang, Wentao Duan, Zhifeng Medicine (Baltimore) 5600 Thrombosis is one of the serious complications related to prophylactic balloon occlusion of the abdominal aorta (PBOAA). This study aims to retrospectively analyze the efficacy and safety of continuous low-flow infusion of diluted heparin saline to prevent this complication related to PBOAA and further to provide the theory and evidences for using PBOAA. A study was carried out at our hospital from March 2016 to December 2018. Women with pernicious placenta previa (PPP) were treated PBOAA to prevent massive bleeding during CS. According to whether continuous low-flow infusion of diluted heparin saline was used to prevent catheter-related thrombosis or not, they were divided into 2 groups, the test group and the control group. The incidence of thrombosis between the 2 groups was compared and the effective treatment of thrombosis was also discussed. The comparison of nonparametric values was accomplished by using Fisher exact test. Statistical significance was set at P < .05. There were 31 women with PPP who received PBOAA during CS who were included in our study. Six of 19 women in control group (31.6%) developed thrombotic complications, while none of 12 women in test group. There were statistically significant differences in the incidence of thrombosis between the 2 groups (P = .037). There was no statistically significant difference in the amount of estimated blood loss and blood transfusion during CS between the 2 groups, nor was there statistically significant difference in the hospital days after CS (P > .05). All 6 women with thrombotic complications had no positive symptoms and thrombotic sequelae. The managements of thrombus included systemic anticoagulation, catheter-directed thrombolysis, and catheter-directed anticoagulation. One of the 6 women was lost to follow-up, and the thrombus of the other 5 women were completely dissolved. No other adverse outcomes or complications related to PBOAA were observed in all women in this study. Continuous low-flow infusion of diluted heparin saline is a safe procedure when PBOAA is performed for patients with PPP. It can effectively reduce or even avoid thrombosis without increasing intraoperative blood loss during CS for PPP patients. Wolters Kluwer Health 2019-12-20 /pmc/articles/PMC6940061/ /pubmed/31861017 http://dx.doi.org/10.1097/MD.0000000000018446 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 5600
Luo, Rongguang
Wang, Fen
Guan, Yanxing
Wan, Junhui
Zhang, Wentao
Duan, Zhifeng
A retrospective analysis of the treatment on abdominal aortic balloon occlusion-related thrombosis by continuous low-flow diluted heparin
title A retrospective analysis of the treatment on abdominal aortic balloon occlusion-related thrombosis by continuous low-flow diluted heparin
title_full A retrospective analysis of the treatment on abdominal aortic balloon occlusion-related thrombosis by continuous low-flow diluted heparin
title_fullStr A retrospective analysis of the treatment on abdominal aortic balloon occlusion-related thrombosis by continuous low-flow diluted heparin
title_full_unstemmed A retrospective analysis of the treatment on abdominal aortic balloon occlusion-related thrombosis by continuous low-flow diluted heparin
title_short A retrospective analysis of the treatment on abdominal aortic balloon occlusion-related thrombosis by continuous low-flow diluted heparin
title_sort retrospective analysis of the treatment on abdominal aortic balloon occlusion-related thrombosis by continuous low-flow diluted heparin
topic 5600
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940061/
https://www.ncbi.nlm.nih.gov/pubmed/31861017
http://dx.doi.org/10.1097/MD.0000000000018446
work_keys_str_mv AT luorongguang aretrospectiveanalysisofthetreatmentonabdominalaorticballoonocclusionrelatedthrombosisbycontinuouslowflowdilutedheparin
AT wangfen aretrospectiveanalysisofthetreatmentonabdominalaorticballoonocclusionrelatedthrombosisbycontinuouslowflowdilutedheparin
AT guanyanxing aretrospectiveanalysisofthetreatmentonabdominalaorticballoonocclusionrelatedthrombosisbycontinuouslowflowdilutedheparin
AT wanjunhui aretrospectiveanalysisofthetreatmentonabdominalaorticballoonocclusionrelatedthrombosisbycontinuouslowflowdilutedheparin
AT zhangwentao aretrospectiveanalysisofthetreatmentonabdominalaorticballoonocclusionrelatedthrombosisbycontinuouslowflowdilutedheparin
AT duanzhifeng aretrospectiveanalysisofthetreatmentonabdominalaorticballoonocclusionrelatedthrombosisbycontinuouslowflowdilutedheparin
AT luorongguang retrospectiveanalysisofthetreatmentonabdominalaorticballoonocclusionrelatedthrombosisbycontinuouslowflowdilutedheparin
AT wangfen retrospectiveanalysisofthetreatmentonabdominalaorticballoonocclusionrelatedthrombosisbycontinuouslowflowdilutedheparin
AT guanyanxing retrospectiveanalysisofthetreatmentonabdominalaorticballoonocclusionrelatedthrombosisbycontinuouslowflowdilutedheparin
AT wanjunhui retrospectiveanalysisofthetreatmentonabdominalaorticballoonocclusionrelatedthrombosisbycontinuouslowflowdilutedheparin
AT zhangwentao retrospectiveanalysisofthetreatmentonabdominalaorticballoonocclusionrelatedthrombosisbycontinuouslowflowdilutedheparin
AT duanzhifeng retrospectiveanalysisofthetreatmentonabdominalaorticballoonocclusionrelatedthrombosisbycontinuouslowflowdilutedheparin